APAC Ablation Device Market size is poised to reach USD 3.5 billion by 2028, according to a latest forecast report by Graphical Research.
Continuous technological advancements in ablation devices for better efficiency and accuracy will impel the market size. Ongoing developments in ablation technology offer enhanced success rate, minimal pain, ease of use, higher efficacy, and lower post-procedural complications, thus fueling the patient preference for ablation procedures. Thus, the increase in availability of advanced technology that enables ablation devices products in healthcare facilities will benefits the market revenue growth. Moreover, high investment in research and development activities by several companies for the development of innovative products is projected to drive the market growth.
Rising demand for minimally invasive procedures for treatment of chronic disorders will propel the industry growth. Additionally, upsurge in adoption of minimally invasive surgical treatments in elderly population due to high risk of surgical treatments and associated post-surgical complications is expected to enhance the product adoption. Growing extensiveness of chronic disorders with a high risk of severe health complications will accelerate the patient preference towards ablation procedures. Further, growing awareness campaigns and government initiatives for awareness of several chronic diseases and educating people regarding associated treatments in the region to reduce chronic disease burden will spur the industry outlook. Increasing accessibility to minimally invasive ablation procedural technologies will offer unprecedented growth opportunities to the market.
The ultrasound devices segment accounted more than USD 70 million revenue in 2021 attributed to numerous advantages associated with ultrasound ablation procedures including shorten procedural time, minimal biomechanical effect, ease of use and patient convenience. Furthermore, the integration of several advanced technologies such as extracorporeal shock wave therapy (ECWT) and high-intensity focused ultrasound (HIFU) in ablation procedures for enhanced success rate and safety will boost the market growth. Thus, high investment in R&D activities for continuous advancements in ultrasound ablation devices and introduction of new products in the market.
Browse detailed statistical insights from the report, “Asia Pacific Ablation Devices Market Forecast 2028 By Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices), By Application (Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers), Research Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The oncology segment held over 30% market share in 2021 due to increasing prevalence rate of cancer coupled with rising elderly population base in the region. Moreover, growing accessibility to highly developed ablation devices for cancer treatment among healthcare facilities will fortify the market demand.
The ambulatory surgical centers segment exceeded USD 400 million revenue in 2021 owing to the growing network of ASC facilities for outpatient treatments across the region. Government initiatives to broaden accessibility of advanced treatments to cater to a large patient pool in the developing countries will stimulate the segmental demand. Furthermore, easy availability and integration of advanced technologies in facilities along with presence of high skilled healthcare professionals will further offer unprecedented growth opportunities to the market.
India ablation device industry will grow at 12.8% CAGR during the forecast timeline propelled by growing aging population in the country. Growing trends of sedentary lifestyle, unhealthy dietary habits, excessive tobacco consumption and high intake of caffeine will propel the incidence of chronic diseases such as cancer, gynecological disorders, and cardiovascular diseases thereby augmenting demand for ablation treatment procedures in the country. Further, favorable regulatory scenario for new product development will offer development opportunities to the companies in India. Moreover, developing healthcare infrastructure, increasing per capita income and growing healthcare expenditure will drive the market growth.
The APAC ablation device market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:
Asia Pacific Market, By Product
- Radiofrequency devices
- Laser/light devices
- Ultrasound devices
- Cryoablation devices
Asia Pacific Market, By Application
- Cosmetic surgery
Asia Pacific Market, By End-use
- Ambulatory surgical centers
The above information has been provided for the following countries:
- Asia Pacific
- South Korea